Open Access

Thoracic and respirable particle definitions for human health risk assessment

  • James S Brown1Email author,
  • Terry Gordon2,
  • Owen Price3 and
  • Bahman Asgharian4
Particle and Fibre Toxicology201310:12

DOI: 10.1186/1743-8977-10-12

Received: 4 May 2012

Accepted: 3 February 2013

Published: 10 April 2013

Abstract

Background

Particle size-selective sampling refers to the collection of particles of varying sizes that potentially reach and adversely affect specific regions of the respiratory tract. Thoracic and respirable fractions are defined as the fraction of inhaled particles capable of passing beyond the larynx and ciliated airways, respectively, during inhalation. In an attempt to afford greater protection to exposed individuals, current size-selective sampling criteria overestimate the population means of particle penetration into regions of the lower respiratory tract. The purpose of our analyses was to provide estimates of the thoracic and respirable fractions for adults and children during typical activities with both nasal and oral inhalation, that may be used in the design of experimental studies and interpretation of health effects evidence.

Methods

We estimated the fraction of inhaled particles (0.5-20 μm aerodynamic diameter) penetrating beyond the larynx (based on experimental data) and ciliated airways (based on a mathematical model) for an adult male, adult female, and a 10 yr old child during typical daily activities and breathing patterns.

Results

Our estimates show less penetration of coarse particulate matter into the thoracic and gas exchange regions of the respiratory tract than current size-selective criteria. Of the parameters we evaluated, particle penetration into the lower respiratory tract was most dependent on route of breathing. For typical activity levels and breathing habits, we estimated a 50% cut-size for the thoracic fraction at an aerodynamic diameter of around 3 μm in adults and 5 μm in children, whereas current ambient and occupational criteria suggest a 50% cut-size of 10 μm.

Conclusions

By design, current size-selective sample criteria overestimate the mass of particles generally expected to penetrate into the lower respiratory tract to provide protection for individuals who may breathe orally. We provide estimates of thoracic and respirable fractions for a variety of breathing habits and activities that may benefit the design of experimental studies and interpretation of particle size-specific health effects.

Keywords

Size-selective sampling Fine and coarse particles

Background

It has long been recognized that the regional pattern of particle deposition in the respiratory tract affects the pathogenic potential of inhaled aerosols. For example, Morgan [1] concluded that respirable dusts likely caused pneumoconiosis and silicosis in coal miners, whereas a larger size fraction caused bronchitis and obstructive changes in pulmonary function. Sampling the total air concentration of particulate matter (PM) provides a crude estimate of exposure that may not correlate with observed health effects if the risk is associated only with those particles that may enter the thorax or penetrate beyond the ciliated airways. The concept of size-selective particle sampling has been employed as a means for effectively sampling the particle sizes associated with specific pathologic outcomes (e.g., the respirable fraction with parenchymal disease). If an environmentally or occupationally related particle is recognized to only affect the gas-exchange region of the lung, then a sampling strategy that only collects the respirable fraction of airborne PM is preferable to sampling total suspended particulate (TSP) or the thoracic fraction.

The human respiratory tract can be divided into three main regions based on size, structure, and function, namely, the head, tracheobronchial region (also known as the conducting airways), and the gas-exchange region (also known as the parenchymal, alveolar, or pulmonary) region. Size-selective sampling is intended to help discern the amount of aerosol expected to be available for deposition in a region. Most sampling conventions have been defined in terms of particle penetration into respiratory regions rather than the expected particle deposition or dose to regions. Specific definitions used herein, adopted from the European Committee for Standardization (CEN), are [2]:

  • Inhalable fraction – the mass fraction of total airborne particles which is inhaled through the nose and mouth.

  • Extrathoracic fraction – the mass fraction of inhaled particles failing to penetrate beyond the larynx.

  • Thoracic fraction – the mass fraction of inhaled particles penetrating beyond the larynx.

  • Respirable fraction – the mass fraction of inhaled particles penetrating to the unciliated airways.a

The above definitions are stated in terms of a mass fraction. Relative to total airborne particles, the particle size having 50% penetration for the thoracic and respirable fractions are 10 μm and 4.0 μm (all particle sizes are aerodynamic diameter unless expressed otherwise), respectively [2, 3]. These criteria were specifically developed for workplace atmospheres. Since particles must generally become deposited to exert biological effects, these conventions, based on regional exposure (i.e., particles penetrating into a region of the respiratory tract), are conservative by design in that they overestimate the amount of inhaled material that becomes deposited and thereby available to induce an effect.

In 1985, the American Conference of Governmental Industrial Hygienists (ACGIH) recommended particle size-selective sampling in setting threshold limit values for occupational exposures [4].b The ACGIH specifically considered a reference worker (weight, 70 kg; height, 175 cm) breathing orally while engaged in light activity (minute ventilation, 21.75 liters/min). Criteria were established for Inspirable (now Inhalable), Thoracic, and Respirable Particulate Mass that were intended to be protective against materials that were considered hazardous when deposited anywhere in the respiratory tract, anywhere within the lungs, and in the gas-exchange region, respectively. These criteria were based on exposure of a respiratory tract region (based on particle penetration into that region), not particle deposition in a respiratory tract region. The ACGIH committee recognized uncertainty related to individual biological variability in respiratory health status, breathing patterns (rate and route), and airways structure as well as differences in work rates, all of which can cause differences in inhaled aerosol deposition and dose. Facing these uncertainties, the committee afforded extra protection to exposed workers by over representing the true penetration of particles into regions of the respiratory tract as illustrated in Figure 1 [4].
https://static-content.springer.com/image/art%3A10.1186%2F1743-8977-10-12/MediaObjects/12989_2012_Article_238_Fig1_HTML.jpg
Figure 1

Thoracic particulate mass fraction criteria (relative to total airborne particles) for size-selective sampling. Individual data points are observed human head penetration efficiency during oral inhalation for an inspiratory flow rate of 43.5 L/min, i.e., light exercise [57]. As stated by ACGIH [3], the sampling criterion is offset to the right of experimental data to overestimate the amount of exposure to the lower respiratory tract, i.e., the lungs, and correspondingly to provide a greater level of protection for exposed workers. From ACGIH®, Particle Size-Selective Sampling in the Workplace, Report of the ACGIH ® Technical Committee on Air Sampling Procedures. Copyright 1985. Reprinted with permission. Courtesy: Dr. Otto G. Raabe.

Size-selective sampling has also been employed by the U.S. Environmental Protection Agency (EPA) in setting the national ambient air quality standards (NAAQS) for particulate matter (PM). In 1987, the EPA changed the indicator for PM from TSP (effectively an aerodynamic cut-size varying from 25 to 40 μm, depending on wind speed and direction) to PM10 (particles with a nominal mean aerodynamic diameter ≤ 10 μm) [8]. Consistent in concept with the ACGIH thoracic particle fraction, PM10 delineates a subset of inhalable particles (referred to as thoracic particles) that are thought small enough to penetrate to the thoracic region (including the tracheobronchial and alveolar regions) of the respiratory tract.c In 1997, the EPA extended size-selective sampling to include fine particles indicated by PM2.5 (particles with a nominal mean aerodynamic diameter ≤ 2.5 μm) and retained PM10 as the indicator for thoracic coarse particles [9]. The selection of PM2.5 by the EPA was mainly to delineate the atmospheric fine (combustion derived, aggregates, acid condensates, secondary aerosols) and coarse (crustal, soil-derived dusts) PM modes and for consistency with community epidemiologic health studies reporting various health effects associated with PM2.5. With consideration to the PM NAAQS, Miller et al. [10] also specifically recommended a particle size cut-point of ≤ 2.5 μm as an indicator for fine PM based on consideration of particle penetration into the gas-exchange region and the delineation of the fine and coarse particle modes.

Most recently, the International Organization for Standardization (ISO) has released recommendations for sampling conventions based on particle deposition (rather than exposure) in adult males and females engaged in activities of sitting, light exercise and heavy exercise as specified in Table 1 [11]. The ISO estimates of deposition were determined using the International Commission on Radiological Protection (ICRP) human respiratory tract model [12]. These new ISO conventions [11] are not considered further herein as current sampling conventions for occupational and non-occupational settings remain dependent on the probability of particle penetration rather than deposition in specific regions of the respiratory tract.
Table 1

Ventilatory and activity patterns for adult males, adult females, and a ten year-old child

 

Sleeping

Sitting

Light

Heavy

   

Exercise

Exercise

Adult Male

VT (mL)

625

750

1250

1920

Sedentary worker

f (min-1)

12

12

20

26

 

t (hr)

8.5

5.5

9.75

0.25

 

Vdaily (L/day)

3825

2970

14625

749

Adult Female

VT (mL)

444

464

992

1364

Sedentary worker

f (min-1)

12

14

21

33

 

t (hr)

8.5

5.5

9.75

0.25

 

Vdaily (L/day)

2717

2144

12187

675

Child (10 yrs)

VT (mL)

304

333

583

752

Male or Female

f (min-1)

17

19

32

45

 

t (hr)

10

4.67

9.33

0

 

Vdaily (L/day)

3101

1772

10447

0

VT, tidal volume; f, breathing frequency; t, time spent engaged in specific activity; Vdaily, total volume inspired in 24 hr. Data are from ICRP [12] Tables B15 and B16A-B for breathing and activity patterns, respectively.

Conceptually, size-selective sampling better characterizes PM exposure to regions of the respiratory tract and thereby affords more appropriate avenues for protection of exposed populations than TSP. Such a simple concept is not, however, without ambiguity in definitions and debate over appropriate sampling approaches. For example, the definition for the thoracic fraction specifies particles “penetrating beyond the larynx,” whereas the ACGIH thoracic convention for sampling (Figure 1) clearly and intentionally overestimates the fraction of large particles penetrating into the thoracic region to afford extra protection of occupationally exposed individuals. The purpose of this paper is to provide realistic estimates of thoracic and respirable particle fractions for adults and children that may be used in the design of experimental studies and interpretation of health effects evidence.

The ICRP human respiratory tract model [12] was used to estimate particle penetration through the extrathoracic (ET) airways. The ICRP predictive equations for ET deposition are based on experimental measurements in humans. Although also based on human data, the ICRP model was not used to estimate penetration through the tracheobronchial (TB) airways due to its reliance on measurements of particle clearance from the TB airways and the ability to target particle deposition into the ciliated airways. That is, much of the available regional deposition data for the TB and alveolar regions have been obtained from experiments with radioactively labeled, poorly soluble particles or by use of aerosol bolus techniques (see Sections D.9.2 and E.5.3 of Ref [12]). Aerosol bolus (40 ml volume of 3.5 μm particles) inhaled to a very shallow lung volume (70 ml, ~75% of phase I inert gas washout) by healthy adults (10 M, 6 F; 20-43 yrs of age) show preferential left lung deposition and 23% retention at 48 hrs [13]. This suggests slow TB airway clearance and/or some penetration into the alveolar region. Given the above, coupled with uncertainty related to slow TB clearance [e.g., [14, 15], we utilized the publicly available multiple path particle dosimetry (MPPD; ver 2.1, © 2009) model to estimate penetration through the TB airways.

Methods

Once particles have entered the respiratory tract via the nose or mouth, the primary factors affecting particle penetration into the lower respiratory tract (i.e., beyond the larynx) are airways size and structure, breathing pattern (flow and volume), route of breathing (nose vs. mouth), and inhaled particle size. With regard to particle size, we have considered particles whose deposition is governed by their inertial properties, i.e., ≥ 0.5 μm. Breathing patterns vary mainly by sex, age, and activity. Table 1 provides the breathing patterns, subject groups, and activity patterns from the ICRP [12] model that were used in our assessment.

Based on our comparison of the ICRP model [12] to more recent data provided by Brochu et al. [16], the daily ventilation rates and activity patterns provided in Table 1 overestimate typical daily ventilation rates. Table 2 provides daily ventilation rates (5th, 50th, and 95th percentiles) reported by Brochu et al. [16]. The daily ventilation rates from the ICRP [12] model’s recommended time budget roughly correspond to the highly active 95th percentile (see Table 1 vs. Table 2). To assess the effect of daily activity/ventilation rates on particle penetration into the respiratory tract, we reduced the estimated time (given in Table 1) that individuals spent engaged in light exercise and correspondingly increased their time sitting to match the daily ventilation rates in Table 2. To match the very sedentary 5th percentile of daily activity, it was necessary also to eliminate time spent by the adult female engaged in heavy exercise and to attribute all of the child’s activity to sleeping. Even when considering 100% of the child’s activity equivalent to sleeping, the ICRP [12] breathing pattern slightly overestimated (by 3%; 7.4 vs. 7.2 m3/day) the 5th percentile daily ventilation rates of Brochu et al. [16].
Table 2

Daily ventilation rates (V daily ). a

 

V daily(m 3/day)

 

Very sedentary

Median

Highly active

 

5 thpercentile

50 thpercentile

95 thpercentile

Male b

12.86

17.48

22.11

Female b

9.91

13.67

17.42

Children c

7.20

10.22

13.24

a Data are from Table 2 of Brochu et al. [16]; b values for age range of 23 to <30 years; c average of male and female values for age range of 7 to <11 years.

Route of breathing varies with inspiratory flows and generally shifts from nasal to oronasal breathing at higher flows. The ICRP [12] model characterizes breathing habit based on Niinimaa et al. [17], who examined the route of breathing as a function of activity in healthy adults (14 males, 16 females). Eighty-seven percent of the subjects breathed through the nose at rest and switched to oronasal breathing with exercise. These subjects were referred to as “normal augmenters.” Thirteen percent breathed oronasally even at rest and were referred to as “mouth-breathers.” For both of these breathing habits (i.e., normal augmenters and mouth-breathers, we estimated the fraction of a breath passing through the oral and nasal pathways from regression equations for oral breathing in Figure 1 of the Niinimaa et al. study [17]. The ICRP [12] model utilizes this same general approach, but for each breathing habit and activity (i.e., sleeping, sitting, etc.), the same fraction of oral breathing was assumed applicable to all ages and both sexes.

In considering breathing habit, we differed from the ICRP, in that we assumed the fraction of oral breathing to differ between adult males and females as a function of their minute ventilation rather than their activity level. However, children tend to have a greater fraction of oral breathing than adults at rest and during exercise [18, 19]. Therefore, consistent with the ICRP, we assumed the fraction of the breath inhaled through the mouth (Fm) in the child engaged in some specific level of activity was equal to that of the adult male engaged in the same level of activity despite the dramatically lower ventilation rates of the child. We also considered recent breathing habit data not available for inclusion in the ICRP model [12]. Bennett et al. [19, 20] show a more gradual increase in oronasal breathing than did Niinimaa et al. [12]. In addition to the normal augmenter and mouth-breather breathing habits based on the Niinimaa et al. [17] study, we also considered the more gradual onset of oronasal breathing observed in adults and children by the Bennett et al. [19, 20] studies, herein termed as “gradual augmenters.”

The gradual augmenter breathing habit for children was estimated by linear regression of the observed minute ventilation and Fm at rest and at 40% maximum physical work capacity from data in Table two and Figure two of Bennett et al. [19] for 12 children (9 M, 3 F; 6-10 yrs of age). The gradual augmenter breathing habit for adult males and females was estimated by linear regression of the observed minute ventilation and Fm at rest and at 60% maximum physical work capacity from data in Table two and Figure three of Bennett et al. [20] for 22 adults (11 M, 11 F; mean age, 22 yrs). In the adult females, the fitted Fm was zero for the activity of sitting and so was also set to zero for the activity of sleep. Table 3 provides the Fm for all breathing habits (normal augmenters, mouth-breathers, and gradual augmenters) used in our simulations. In a study of 37 subjects from 7-72 years of age, James et al. [21] reported that 2 subjects (5.4%) breathed orally only. With this finding in mind, we have also considered purely oral breathing in our estimates of particle penetration into regions of the lower respiratory tract.
Table 3

Partitioning of breaths through the mouth and nose

 

Sleeping

Sitting

Light

Heavy

   

Exercise

Exercise

Adult Male

Normal Augmenter a

0, 1.00 d

0, 1.00

0, 1.00

0.52, 0.48

 

Mouth-breather a

0.29, 0.71

0.36, 0.64

0.59, 0.41

0.66, 0.34

Gradual Augmenter b

0.12, 0.88

0.13, 0.87

0.29, .071

0.54, 0.46

Adult Female

Normal Augmenter a

0, 1.00

0, 1.00

0, 1.00

0.50, 0.50

 

Mouth-breather a

0.12, 0.88

0.23, 0.77

0.57, 0.43

0.65, 0.35

Gradual Augmenter b

0, 1.00

0, 1.00

0.22, 0.78

0.59, 0.41

Child

Normal Augmenter a

0, 1.00

0, 1.00

0, 1.00

0.51, 0.49

 

Mouth-breather a

0.29, 0.71

0.36, 0.64

0.59, 0.41

0.66, 0.34

 

Gradual Augmenter c

0.29, 0.71

0.31, 0.69

0.51, 0.49

0.77, 0.23

a From regression equations for oral breathing in Figure 1 of Niinimaa et al. [17]; b Data based on Table 2 and Figure 3 of Bennett et al. [20] for 22 individuals (11 M, 11 F; mean age, 22 yrs); c Data based on Table 2 and Figure 2 of Bennett et al. [19] for 12 children (9 M, 3 F; 6-10 yrs of age); d fraction inhaled through mouth, fraction inhaled through nose.

For air passing through the mouth, deposition of large particles by impaction occurs mainly at the larynx. From Eq D.30 of ICRP [12], laryngeal deposition efficiency, η(ET)larynx, is given by:
η ET larynx = 1 1.1 × 10 4 d a 2 Q total S F 3 0.6 Vt S F t 3 0.2 1.4 + 1 1 https://static-content.springer.com/image/art%3A10.1186%2F1743-8977-10-12/MediaObjects/12989_2012_Article_238_Equ1_HTML.gif
(1)

where: da is aerodynamic diameter (μm); Qtotal is total inspiratory flow rate (mL/s); VT is tidal volume (mL); and SFt is a scaling factor of 1.0 for adult males, 1.08 for adult females, and 1.26 for ten year-old children from Table fifteen of ICRP [12].

For nasal breathing, ET deposition efficiency due to impaction was calculated from Eq. D.32 and D.33 of ICRP [12]. The ET deposition efficiencies for the anterior, η(ET1)nose, and posterior, η(ET2)nose, nasal regions are given by:
η E T 1 nose = 0.5 1 3 × 10 4 d a 2 Q nose S F t 3 + 1 1 https://static-content.springer.com/image/art%3A10.1186%2F1743-8977-10-12/MediaObjects/12989_2012_Article_238_Equ2_HTML.gif
(2)
η E T 2 nose = 1 5.5 × 10 5 d a 2 Q nose S F t 3 1.17 + 1 1 https://static-content.springer.com/image/art%3A10.1186%2F1743-8977-10-12/MediaObjects/12989_2012_Article_238_Equ3_HTML.gif
(3)

where: Qnose is the inspiratory flow (mL/s) through the nose. The use of SFt in Equations 2 and 3 presumes that nasal deposition efficiency increases with decreasing body size and increasing nasal resistance. Two studies [19, 22] suggest that the nasal deposition in children is less than that of adults. These two studies, not considered in the ICRP model [12], suggest that it may be inappropriate to apply a scaling factor for nasal deposition of children. Accordingly, we estimated the nasal deposition efficiency of the 10 yr old child for a SFt of both 1.0 (child-A) and 1.26 (child-B). Additionally, we estimated the upper and lower 95% confidence bounds for inter-individual variability attributable to differences in deposition efficiency within the ET region predicted by Equations 1-3 as specified in paragraphs D44 and D68 of ICRP [12].

The deposition efficiencies along the ET pathways (i.e., nasal and oral) were assumed to be independent. As such, total ET deposition was taken to be the sum of deposition between the pathways weighted by the flow partitioning (see Paragraph 161 of ICRP [12]). The thoracic fraction, defined as particle penetration past the larynx, P(ET), is given by:
P ET = 1 F m η ET larynx 1 F m × η E T 1 nose + 1 η E T 1 nose η E T 2 nose https://static-content.springer.com/image/art%3A10.1186%2F1743-8977-10-12/MediaObjects/12989_2012_Article_238_Equ4_HTML.gif
(4)
We estimated inspiratory deposition efficiency in the TB region, ηTB, of particles (0.5-20 μm; 0.1 μm increments) using the publicly available multiple path particle dosimetry (MPPD; ver 2.1, © 2009) model.d The model considers deposition by the mechanisms of impaction, sedimentation, and diffusion. The approach and formula used to calculate particle losses in the MPPD model are described by Anjilvel and Asgharian [23]. Physiological input parameters (namely, tidal volume [VT], breathing frequency [f], functional residual capacity [FRC], and upper respiratory tract volume [URT]), necessary for MPPD simulations are provided in Tables 1 and 4. FRC and URT for each group are from Table fifteen of ICRP [12]. The Yeh and Schum [24] typical path whole lung model was utilized and scaled for FRC and VT. The effects of these physiologic parameters on deposition in humans free of respiratory disease are described by de Winter-Sorkina and Cassee [25].
Table 4

Functional residual volume (FRC) and upper respiratory tract volumes (URT)

 

FRC (mL)

URT (mL)

Adult Male

3300

50

Adult Female

2680

40

Child (10 yrs)

1484

25

https://static-content.springer.com/image/art%3A10.1186%2F1743-8977-10-12/MediaObjects/12989_2012_Article_238_Fig2_HTML.jpg
Figure 2

Thoracic fraction, i.e., particle penetration through the extrathoracic region, P(ET), as a function of breathing route. Penetration data are with respect to particle diameter as a function of the fraction of air inhaled through the mouth (Fm) in an adult male engaged in light exercise relative to particles entering the respiratory tract. Curves are for the Fm of 0.00, 0.25, 0.50, 0.75, and 1.00 as indicated on the figure. Horizontal red line highlights 50% penetration.

https://static-content.springer.com/image/art%3A10.1186%2F1743-8977-10-12/MediaObjects/12989_2012_Article_238_Fig3_HTML.jpg
Figure 3

Respirable fraction, i.e., particle penetration through the tracheobronchial region, P(TB), as a function of breathing route. Penetration data are with respect to particle diameter as a function of the fraction of air inhaled through the mouth (Fm) in an adult male engaged in light exercise relative to particles entering the respiratory tract. Curves are for the Fm of 0.00, 0.25, 0.50, 0.75, and 1.00 as indicated on the figure. Horizontal red line highlights 50% penetration.

The respiratory fraction, defined as particle penetration through the ciliated airways of the TB region, P(TB), is given by:
P TB = 0 T inh C 1 dt 0 T inh C 0 dt P ET 1 η TB https://static-content.springer.com/image/art%3A10.1186%2F1743-8977-10-12/MediaObjects/12989_2012_Article_238_Equ5_HTML.gif
(5)

where: C0 and C1 are particle concentration passing the larynx and terminal bronchioles, respectively; and Tinh is the time of inhalation. Since conducting airway particle concentration is nearly constant during inhalation, respiratory fraction can be expressed in terms of TB deposition efficiency as given above. An Additional file 1: Appendix to this paper provides estimates of P(TB) based on the ICRP [12] model rather than the MPPD model.

After calculating P(ET) and P(TB) for all activities and individual groups, daily average estimates of P(ET)avg and P(TB)avg weighted by daily ventilation (see Tables 1 and 2) were calculated as a function of particle size. Ventilation-weighted averages of P(ET)avg for each particle size were calculated as:
P ET avg = i = 1 n P ET i V daily i / i = 1 n V daily i https://static-content.springer.com/image/art%3A10.1186%2F1743-8977-10-12/MediaObjects/12989_2012_Article_238_Equ6_HTML.gif
(6)

where: P(ET)i is the ET fraction for activity, i; Vdaily-i is the daily volume inhaled while engaged in activity, i; and n is the number of activities. Ventilation-weighted averages of P(TB)avg were computed similarly to those of P(ET)avg.

Finally, thoracic and respiratory particle fractions were also calculated after applying the ICRP [12] inhalability criterion assuming no ambient wind, 1−0.5 [1− (0.00076 da 2.8 + 1) −1]. The ICRP [12] criterion was utilized as it better represents the inhalation of particles <10 μm than the ACGIH and CEN [2, 3] criterion.

Results

We estimated particle penetration fractions into the thorax and respiratory region of an adult male, adult female, and a 10 yr old child. In the results described below, data do not consider particle inhalability unless specifically stated. Inhalability was not considered since, as the results will show, it has a minimal affect on 50% cut-points for particle penetration into the lower airways for all breathing habits except the less probable condition of oral breathing.

Route of breathing

Of the factors we considered, route of breathing (or breathing habit) had the greatest effect on estimates of P(ET) and P(TB). Figure 2 and 3 illustrate P(ET) and P(TB) for an adult male engaged in light exercise as a function of Fm. In Figure 2, fifty percent P(ET) occurs at the da of 1.8 , 2.7, 4.4, 6.1, and 7.0 μm for the Fm of 0.00, 0.25, 0.50, 0.75, and 1.00, respectively. Note that the curve in Figure 2 for Fm=1 is for comparable conditions to those for which ACGIH [4] thoracic fraction was based, i.e. an orally breathing adult male engaged in light exercise. In Figure 3, fifty percent P(TB) occurs at the da of 1.7 , 2.5, 3.8, 5.1, and 5.7 μm for the Fm of 0.00, 0.25, 0.50, 0.75, and 1.00, respectively. As ventilation is shifted to the lower removal efficiency oral passages, there is an ever greater separation between the P(ET) and P(TB) curves. By contrast, for purely nasal breathing (Fm = 0, the case for normal augmenters during light exercise), due to the vast removal of particles in the nasal airways, there is nearly no difference between the P(ET) and P(TB) curves in Figures 2 and 3, respectively.

Table 5 provides the 50% cut-points for particle penetration into the thorax and respiratory region for all the breathing habits we evaluated. As may be expected based on Fm (see Table 3), the predicted particle penetration for the gradual augmenter breathing habit is enveloped between that of the normal augmenter and mouth-breathers. Additionally, consistent with Figures 2 and 3, Table 5 shows that the largest 50% cut-points are observed during the case of oral breathing. Table 6 provides data on the penetration of 10 μm particles into the lower respiratory tract which is generally less than 20%, except for the case of oral breathing where penetration into the thorax can approach 40%.
Table 5

Particle penetration (50% cut-point) through respiratory tract regions relative to particles entering the respiratory tract

V daily(%-tile)

Normal

 

Gradual

 
 

Augmenter

Mouth-breather

Augmenter

Oral only

 

P(ET) avg

P(TB) avg

P(ET) avg

P(TB) avg

P(ET) avg

P(TB) avg

P(ET) avg

P(TB) avg

Male

        

5%

2.94 a

2.74

5.15

4.32

3.60

3.25

9.00

6.67

95% CI

(1.72–5.03)

(1.65–4.34)

(3.12–8.48)

(2.84–6.10)

(2.11–6.11)

(2.00–4.98)

(5.86–13.8)

(5.00–8.14)

50%

2.46

2.30

5.09

4.30

3.37

3.05

8.09

6.11

95% CI

(1.44–4.20)

(1.38–3.71)

(3.14–8.26)

(2.86–5.88)

(1.99–5.67)

(1.88–4.65)

(5.26–12.4)

(4.58–7.34)

95%

2.14

2.03

5.08

4.31

3.19

2.90

7.61

5.89

95% CI

(1.25–3.66)

(1.20–3.32)

(3.16–8.16)

(2.89–5.83)

(1.90–5.33)

(1.79–4.44)

(4.95–11.7)

(4.38–7.07)

Female

        

5%

2.92

2.71

4.32

3.78

3.10

2.86

8.78

6.50

95% CI

(1.71–5.01)

(1.63–4.28)

(2.57–7.22)

(2.40–5.52)

(1.81–5.30)

(1.73–4.48)

(5.71–13.5)

(4.88–7.91)

50%

2.42

2.27

4.46

3.87

2.91

2.68

7.88

5.96

95% CI

(1.41–4.13)

(1.36–3.64)

(2.72–7.32)

(2.51–5.45)

(1.71–4.94)

(1.63–4.19)

(5.13–12.1)

(4.47–7.17)

95%

2.10

1.99

4.58

3.96

2.74

2.54

7.44

5.77

95% CI

(1.23–3.60)

(1.18–3.26)

(2.82–7.42)

(2.60–5.49)

(1.61–4.64)

(1.53–4.00)

(4.84–11.4)

(4.29–6.94)

Child-B b

        

5%

2.77

2.61

4.31

3.78

4.30

3.78

8.34

6.46

95% CI

(1.62–4.75)

(1.56–4.18)

(2.58–7.19)

(2.40–5.57)

(2.57–7.17)

(2.40–5.56)

(5.42–12.8)

(4.74–8.04)

50%

2.25

2.13

4.37

3.81

4.07

3.59

7.50

5.81

95% CI

(1.31–3.85)

(1.27–3.48)

(2.67–7.15)

(2.47–5.35)

(2.46–6.71)

(2.29–5.15)

(4.88–11.5)

(4.32–7.08)

95%

1.89

1.81

4.34

3.76

3.98

3.49

6.91

5.33

95% CI

(1.11–3.24)

(1.07–2.98)

(2.69–7.03)

(2.48–5.11)

(2.45–6.47)

(2.27–4.88)

(4.49–10.6)

(4.01–6.36)

Child-A c

        

5%

3.92

3.56

5.60

4.72

5.59

4.72

8.34

6.46

95% CI

(2.29–6.72)

(2.18–5.44)

(3.38–9.28)

(3.09–6.63)

(3.37–9.27)

(3.09–6.62)

(5.42–12.8)

(4.74–8.04)

50%

3.18

2.94

5.37

4.53

5.12

4.36

7.50

5.81

95% CI

(1.86–5.45)

(1.77–4.58)

(3.29–8.77)

(3.03–6.10)

(3.11–8.40)

(2.88–5.95)

(4.88–11.5)

(4.32–7.08)

95%

2.68

2.50

5.16

4.34

4.85

4.14

6.91

5.33

95% CI

(1.56–4.58)

(1.50–3.97)

(3.19–8.34)

(2.94–5.66)

(2.98–7.90)

(2.76–5.51)

(4.49–10.6)

(4.01–6.36)

P(ET)avg, extrathoracic particle penetration which is the thoracic particle fraction averaged across all activity levels weighted by daily ventilation; P(TB)avg, tracheobronchial particle penetration which is the respirable particle fraction averaged across all activity levels weighted by daily ventilation; 95% CI, ninety-five percent confidence intervals for inter-individual variability attributable to differences in particle penetration through the extrathoracic region; a Aerodynamic particle diameter in μm; b Scaling factor in Equations 2 and 3 equal to 1.26; c Scaling factor in Equations 2 and 3 equal to 1.0.

Table 6

Penetration of 10 μm (d a ) through respiratory tract regions relative to particles entering the respiratory tract

V daily(%-tile)

Normal

 

Gradual

 
 

Augmenter a

Mouth-breather a

Augmenter a

Oral only a

 

P(ET) avg

P(TB) avg

P(ET) avg

P(TB) avg

P(ET) avg

P(TB) avg

P(ET) avg

P(TB) avg

Male

        

5%

0.05b

0.03

0.21

0.10

0.11

0.05

0.43

0.21

50%

0.04

0.02

0.19

0.08

0.11

0.04

0.36

0.15

95%

0.03

0.01

0.19

0.06

0.10

0.03

0.32

0.12

Female

        

5%

0.06

0.03

0.15

0.07

0.06

0.03

0.41

0.20

50%

0.04

0.02

0.15

0.06

0.07

0.02

0.35

0.14

95%

0.03

0.01

0.16

0.05

0.07

0.02

0.31

0.11

Child-B c

        

5%

0.05

0.02

0.16

0.08

0.16

0.08

0.38

0.18

50%

0.03

0.01

0.15

0.06

0.14

0.06

0.31

0.13

95%

0.02

0.01

0.14

0.04

0.13

0.04

0.27

0.09

Child-A d

        

5%

0.10

0.05

0.21

0.10

0.21

0.10

0.38

0.18

50%

0.07

0.04

0.19

0.09

0.18

0.07

0.31

0.13

95%

0.05

0.02

0.17

0.05

0.16

0.05

0.27

0.09

P(ET), extrathoracic penetration for 10 μm particles; P(TB), tracheobronchial penetration for 10 μm particles; aData are daily averages, all activity levels weighted by daily ventilation; bFraction penetration; cScaling factor in Equations 2 and 3 equal to 1.26; dScaling factor in Equations 2 and 3 equal to 1.0.

Age and sex

Daily weighted penetrations curves for P(ET)avg and P(TB)avg are illustrated in Figures 4 and 5, respectively. For normal augmenters and oral breathing, 50% cut-points for P(ET)avg and P(TB)avg were generally similar between adult males and females, but shifted to slightly (<0.2 μm) smaller particle sizes in the females (see Table 5). There was a larger (<0.8 μm) difference in 50% cut-points between males and females for the mouth-breather and gradual augmenter breathing habits which is attributable to greater nasal inhalation by females than males.
https://static-content.springer.com/image/art%3A10.1186%2F1743-8977-10-12/MediaObjects/12989_2012_Article_238_Fig4_HTML.jpg
Figure 4

Thoracic fraction, i.e., particle penetration through the extrathoracic region, P(ET) avg , in adults and a 10 yr-old child. Data are daily averaged values for a median activity level, gradual augmenter breathing habit, and uncorrected for particle inhalability. Child-A and child-B are for a scaling factor of 1.0 and 1.26 in Equations 2 and 3, respectively. Horizontal red line highlights 50% penetration which occurs at 3.1 μm (adult female), 3.4 μm (adult male), 4.1 μm (child-B), and 5.1 μm (child-A).

https://static-content.springer.com/image/art%3A10.1186%2F1743-8977-10-12/MediaObjects/12989_2012_Article_238_Fig5_HTML.jpg
Figure 5

Respirable fraction, i.e., particle penetration through the tracheobronchial region, P(TB) avg , in adults and a 10 yr-old child. Data are daily averaged values for a median activity level, gradual augmenter breathing habit, and uncorrected for particle inhalability. Child-A and child-B are for a scaling factor of 1.0 and 1.26 in Equations 2 and 3, respectively. Horizontal red line highlights 50% penetration which occurs at 2.7 μm (adult female), 3.1 μm (adult male), 3.6 μm (child-B), and 4.4 μm (child-A).

The data for child-A are more consistent, than child-B, with experimental data [19, 22] showing a lower nasal particle removal efficiency in children than adults. For all breathing habits except oral breathing in Table 5, child-A shows larger 50% cut-points than adults. Additionally, in Table 6, the penetration of 10 μm particles into the thoracic and respiratory regions of child-A is generally greater than or equal to that of adults for all breathing habits other than oral. For oral breathing, the penetration of 10 μm particles is lower in child-A than adults.

Activity level

Impaction in the nasal airways, larynx, and large bronchi increases in conjunction with activity and increasing inspiratory flows across the range of da. Therefore, decreasing 50% cut-points for both P(ET)avg and P(TB)avg are observed with increasing activity. In general, the penetration of 10 μm particles into the thoracic and respiratory regions also showed a small reduction with increasing daily activity level (see Table 6). However, the small reductions in particle penetration pale in comparison to the large increases in ventilation and intake of particles that occur with increasing activity level.

Inhalability adjustment

The thoracic and respirable fraction data in Table 5 were relative to particles entering the respiratory tract. For comparison, Table 7 provides da associated with 50% penetration into the thorax and respiration regions after applying inhalability criterion. Adjusting for inhalability shifts penetration curves to smaller particle sizes, and this effect is most evident where there is a low activity level and a substantial contribution of oral breathing. Table 6 provides data on the penetration of 10 μm particles into the lower respiratory tract. Those penetration data may be adjusted for inhalability by multiplying by 0.84, the inhalability of 10 μm particles.
Table 7

Inhalability adjusted particle penetration (50% cut-point) through respiratory tract regions

V daily(%-tile)

Normal

 

Gradual

 
 

Augmenter

Mouth-breather

Augmenter

Oral only

 

P(ET) avg

P(TB) avg

P(ET) avg

P(TB) avg

P(ET) avg

P(TB) avg

P(ET) avg

P(TB) avg

Male

        

5%

2.92 a

2.72

4.97

4.24

3.55

3.22

8.24

6.38

95% CI

(1.71–4.90)

(1.64–4.26)

(3.09–7.66)

(2.81–5.85)

(2.11–5.82)

(2.00–4.85)

(5.66–11.4)

(4.89–7.59)

50%

2.44

2.30

4.93

4.21

3.33

3.02

7.52

5.90

95% CI

(1.43–4.12)

(1.37–3.67)

(3.11–7.51)

(2.84–5.67)

(1.99–5.43)

(1.87–4.54)

(5.12–10.5)

(4.50–6.98)

95%

2.14

2.02

4.92

4.22

3.15

2.88

7.14

5.71

95% CI

(1.25–3.62)

(1.20–3.29)

(3.13–7.44)

(2.87–5.64)

(1.89–5.15)

(1.78–4.36)

(4.84–10.1)

(4.32–6.77)

Female

        

5%

2.90

2.70

4.22

3.72

3.08

2.85

8.06

6.23

95% CI

(1.70–4.87)

(1.63–4.20)

(2.56–6.73)

(2.38–5.34)

(1.81–5.13)

(1.73–4.40)

(5.53–11.2)

(4.78–7.41)

50%

2.41

2.26

4.36

3.81

2.89

2.67

7.35

5.77

95% CI

(1.41–4.06)

(1.35–3.60)

(2.70–6.80)

(2.50–5.29)

(1.71–4.79)

(1.63–4.12)

(5.00–10.3)

(4.39–6.83)

95%

2.10

1.99

4.46

3.89

2.72

2.52

7.00

5.60

95% CI

(1.23–3.55)

(1.18–3.23)

(2.80–6.87)

(2.58–5.33)

(1.61–4.42)

(1.53–3.93)

(4.74–9.91)

(4.22–6.66)

Child-B b

        

5%

2.76

2.60

4.22

3.73

4.21

3.72

7.73

6.20

95% CI

(1.62–4.64)

(1.56–4.11)

(2.56–6.69)

(2.39–5.38)

(2.56–6.68)

(2.39–5.37)

(5.28–10.8)

(4.65–7.52)

50%

2.24

2.13

4.27

3.75

3.99

3.54

7.05

5.63

95% CI

(1.31–3.79)

(1.27–3.44)

(2.65–6.66)

(2.46–5.20)

(2.45–6.30)

(2.28–5.01)

(4.77–9.98)

(4.25–6.74)

95%

1.89

1.80

4.25

3.71

3.91

3.45

6.56

5.21

95% CI

(1.10–3.21)

(1.07–2.96)

(2.67–6.56)

(2.47–4.99)

(2.42–6.12)

(2.25–4.78)

(4.42–9.37)

(3.96–6.15)

Child-A c

        

5%

3.87

3.52

5.40

4.62

5.39

4.61

7.73

6.20

95% CI

(2.28–6.36)

(2.17–5.27)

(3.34–8.32)

(3.07–6.32)

(3.34–8.31)

(3.06–6.31)

(5.28–10.8)

(4.65–7.52)

50%

3.15

2.92

5.20

4.44

4.96

4.28

7.05

5.63

95% CI

(1.85–5.29)

(1.77–4.49)

(3.26–7.96)

(3.00–5.88)

(3.09–7.66)

(2.86–5.75)

(4.77–9.98)

(4.25–6.74)

95%

2.66

2.49

5.00

4.26

4.73

4.07

6.56

5.21

95% CI

(1.56–4.47)

(1.50–3.91)

(3.16–7.64)

(2.92–5.51)

(2.96–7.29)

(2.74–5.39)

(4.42–9.37)

(3.96–6.15)

P(ET)avg, extrathoracic particle penetration which is the thoracic particle fraction averaged across all activity levels weighted by daily ventilation; P(TB)avg, tracheobronchial particle penetration which is the respirable particle fraction averaged across all activity levels weighted by daily ventilation; 95% CI, ninety-five percent confidence intervals for inter-individual variability attributable to differences in particle penetration through the extrathoracic region; a Aerodynamic particle diameter in μm; b Scaling factor in Equations 2 and 3 equal to 1.26; c Scaling factor in Equations 2 and 3 equal to 1.0.

Discussion

We calculated thoracic and respirable particle fractions for an adult male, adult female, and ten year-old child engaged in typical daily activities ranging from sleep to heavy exercise. Our estimates are intended to represent full-day ambient and/or non-ambient exposures while individuals are engaged in a variety of activities. This differs from the ACGIH and CEN criteria which are intended to represent a workplace setting [2, 4]. Similarly, considering the need to provide protection for sensitive individuals who may breathe by mouth and/or oronasally, the EPA [8] selected the nominal cut-point of 10 μm as an indicator of the thoracic fraction consistent with ISO [26, 27] recommendations for occupational or non-occupational environments. Our estimates show less penetration of coarse particulate matter into the thoracic and gas exchange regions of the respiratory tract than current criteria. For typical breathing habits (i.e., not oral breathing), we would predict less than 20% penetration of 10 μm particles into the thorax, whereas a 50% penetration of 10 μm is currently used in both occupational and non-occupational criteria [2, 4, 8, 9]. Recognizing that there are differences in the sources and chemical composition between ambient fine (nominal mean da ≤ 2.5 μm) and larger coarse PM, our finding may, in part, explain why causal relationships are observed between morbidity and mortality with short and long-term exposure to fine PM but not larger coarse PM (see Chapter 2 in Ref [28]).

There are two primary reasons for the dramatic difference between our estimates and the current criteria. First, the ACGIH [4] criteria considered all inspired air to enter via the oral airway which increases the penetration through the ET airways. With the exception of a laboratory setting, however, few individuals breathe exclusively through the mouth. This would make the breathing habits other than oral breathing preferable for the purposes of estimating actual exposures. Second, the ACGIH criteria are intentionally conservative (Figure 1) as the committee chose to afford extra protection by over representing the true penetration of particles into the lower respiratory tract. In Figure 2, we predicted a 50% cut-point of 7.0 μm for the conditions considered by the ACGIH, namely, an orally breathing adult male engaged in light exercise. Additionally, our predicted upper bound 95th percentile for 50% cut-points during oral breathing corrected for inhalability in Table 7 are ~10 μm. Thus, selection of 10 μm as having 50% penetration into the thorax was consistent with over representing the true penetration of particles into the lower respiratory tract of most individuals.

Route of breathing has a dramatic affect on particle delivery to the thoracic and respiratory regions since the deposition efficiency of the nasal passages greatly exceeds that of the oral pathway. Most subjects in the Niinimaa et al. [17] study, 87% (26 of 30), breathed through their nose until an activity level was reached when they switched to oronasal breathing. Thirteen percent (4 of 30) of the subjects, however, were oronasal breathers even at rest. These two subject groups are commonly referred to in the literature (e.g., see [12]) as “normal augmenters” and “mouth-breathers,” respectively. Becquemin et al. [18] and Bennett et al. [19] showed that children tend to have a greater fraction of oral breathing than adults at rest and during exercise. Route of breathing may also vary between races; Bennett et al. [20] found that African-Americans and females had a greater nasal contribution to breathing during exercise than Caucasians and males. The abrupt change in route of breathing occurring in normal augmenters has not been observed by others. The gradual augmenter breathing habit based on Bennett et al. [19, 20] may be preferable to the normal augmenter in representing the general population. Chadha et al. [29] found that the majority (11 of 12) of patients with asthma or allergic rhinitis also breathe oronasally at rest. In healthy individuals, a small fraction (around 5%) may breathe solely through the mouth [21]. Our estimates for gradual augmenters provide particle penetration fractions most typical of healthy populations. Our estimates for mouth-breathers may be more appropriate for patients with mild upper respiratory disease.

The ICRP model [12] appears to underestimate the penetration of particles through the ET airways of children. A SFt is applied in Equations 1-3 with the presumption that oral and nasal particle deposition increase with decreasing body size and increasing flow resistance.

For oral breathing on a mouthpiece, Bennett et al. [30] showed greater ET deposition in children than adults. This finding suggests that the application of a SFt of 1.26 in Eq 1 is appropriate for laryngeal deposition. However, for nasal breathing, Becquemin et al. [22] and Bennett et al. [19] showed less nasal deposition in children than in adults. These two studies, not considered in the ICRP model [12], suggest that it may be inappropriate to apply a SFt in Equations 2 and 3 for nasal deposition in children. Lower nasal deposition of particles in children than adults means greater penetration of particles into the lower respiratory tract of children than adults. Accordingly, we conducted simulations for the child with the SFt in Equations 2 and 3 set equal to 1.0 in addition to the SFt of 1.26 recommended by ICRP [12]. The estimated nasal ET deposition efficiency of 2 μm particles in the normal augmenter child during light exercise decreased from 68% to 48% when the SFt was decreased from 1.26 to 1.0. For comparison, under the same level of activity, the estimated ET deposition efficiency was 57-58% in the adult male and female. Decreasing the nasal deposition efficiency of the child relative to the ICRP model [12] increased the particle size estimated to have 50% penetration into the thoracic and respiratory regions (see Tables 5, 6, 7 and Figures 4 and 5). These estimates of larger 50% cut points for child-A than adults appear consistent with studies in children that were not incorporated into the ICRP model [12].

With the exception of Table 7, the thoracic and respirable fractions that we present are the amount of particles entering a specified respiratory tract region relative to the amount of particles entering the respiratory tract. In effect, we assumed 100% inhalability across the range of particle sizes (0.5-20 μm) examined. We have opted on this convention since the inhalable fraction depends on factors not considered here such as wind speed and direction relative to the exposed individual. For recent reviews of the literature on particle inhalability, the reader is referred to Brown [31] and Millage et al. [32]. Adjusting our data for inhalability, shifts penetration curves to smaller particle sizes, but mainly only where there is a substantial contribution of oral breathing (see Table 7 vs. Table 5).

Conclusion

Our analyses show that occupation and non-occupational criteria for thoracic and respirable fractions overestimate the size of particles entering these regions. As already noted, penetration fractions for workplace criteria were chosen to afford extra protection by over-representing the true penetration of particles into regions of the respiratory tract [4]. However, accepted definitions for thoracic and respirable fractions speak specifically to particles that penetrate into these regions. As such, current occupational and non-occupational criteria may misinform practitioners with regard to the actual size of particles expected to reach regions of the respiratory tract during typical behavior. For instance, the current criteria suggest that 10 μm particles (50%) penetrate into the thorax, thus, leaving the expectation that observed health effects may be modulated by their deposition in either the upper or lower airways. However, we predict that about 20% or less of these 10 μm particles would penetrate through the ET airways and into the lower respiratory tract. Our modifications to the ICRP model [12] related to breathing habit and nasal deposition in children reflect more recent data and provide consistent estimates of greater particle penetration into the thoracic and respiratory regions of children than adults. With those modifications, for median activities, we predict 50% cut-points for P(ET)avg at ~3 μm in adults and ~5 μm in children. The predicted 50% cut-points for P(TB)avg are slightly less than 3 μm in adults and slight greater than 4 μm in children. Our estimates of particle penetration into the thoracic and respiratory regions of the respiratory tract should be useful in the design of experimental studies and interpretation of PM health effects evidence.

Endnotes

aMore typically, the literature has defined this term in relation to the fraction of particles entering the gas-exchange region or the fraction penetrating through the tracheobronchial region, the ciliated airways, or conducting airways.

bFor completeness, other groups such as the British Medical Research Council offered size-selective sampling recommendations prior to the ACGIH. For a historical perspective, the reader is referred to Lippmann [33].

cFor accuracy it should be recognized that the sampler collection efficiency curves for EPA’s PM10 and ACGIH’s thoracic fraction are different. The criteria are similar for particles smaller than the 50% cut-point at 10 μm. However, the curves diverge at about 12 μm, with a dramatic drop in collection efficiency (dictated by policy considerations) for EPA’s PM10, and a more gradual decrease in collection efficiency for the ACGIH criterion.

dThe MPPD model typically outputs estimates of regional deposition for the entire respiratory cycle. For the purposes of this project, the software output was modified by the developers to provide inspiratory deposition fractions for particles in the ET and TB regions. Designating the ET and TB regions as separate compartments, the deposition efficiency in the TB region (ηTB) during inhalation was calculated from the MPPD output as DFTB / (1-DFET), where DFTB and DFET are the deposition fractions of particles in the TB and ET region during inhalation, respectively. For more information about this model, the reader is referred to: http://​www.​ara.​com/​products/​mppd_​capabilities.​htm.

Abbreviations

ACGIH: 

American Conference of Governmental Industrial Hygienists

CEN: 

European Committee for Standardization

da: 

Aerodynamic diameter

DFTB: 

Particle deposition fraction in the TB region during inhalation

DFET: 

Particle deposition fractions in the ET region during inhalation

EPA: 

U.S. Environmental Protection Agency

ET: 

Extrathoracic

f: 

Breathing frequency

Fm: 

Fraction of breath passing through the mouth

FRC: 

Functional residual capacity

ICRP: 

International Commission on Radiological ProtectionISOInternational Organization for Standardization

MPPD: 

Multiple path particle dosimetry

NAAQS: 

National ambient air quality standard

ηTB: 

Particle deposition efficiency in the tracheobronchial region

η(ET)larynx: 

Extrathoracic particle deposition efficiency in the larynx

η(ET1)nose: 

Extrathoracic particle deposition efficiency in anterior nasal region

η(ET2)nose: 

Extrathoracic particle deposition efficiency in posterior nasal region

P(ET): 

Particle penetration past the larynx and the thoracic fraction

P(TB): 

Particle penetration through the ciliated airways and the respirable fraction

PM: 

Particulate matter

PM2.5: 

Particles with a nominal mean aerodynamic diameter ≤ 2.5 μm

PM10: 

Indicator for thoracic coarse particles

Qnose: 

Inspiratory flow through the nose

Qtotal: 

Total inspiratory flow rate

SFt: 

Scaling factor, ratio of trachea diameter in adult reference male to that of subject

t: 

Time spent engaged in specific activity

TB: 

Tracheobronchial

TSP: 

Total suspended particulate

URT: 

Upper respiratory tract volume

Vdaily: 

Total volume inspired in 24 hours

VT: 

Tidal volume.

Declarations

Acknowledgments

The authors thank Drs. Beverly Cohen (NYU), Martin Harper (NIOSH), Mort Lippmann (NYU), and Lindsay Wichers Stanek (U.S. EPA) for their helpful comments. TG was funded, in part, by a faculty appointment with the U.S. EPA through a program administered by Oak Ridge Institute for Science and Education (EPA-ORD/NCEA-RTP-2009-02). This document has been reviewed in accordance with U.S. Environmental Protection Agency policy and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. The views expressed in this article are those of the authors and do not necessarily reflect the views or policies of the U.S. Environmental Protection Agency.

Authors’ Affiliations

(1)
National Center for Environmental Assessment, U.S. Environmental Protection Agency
(2)
NYU School of Medicine
(3)
Applied Research Associates, Inc
(4)
Applied Research Associates, Inc

References

  1. Morgan WK: Industrial bronchitis. Br J Ind Med 1978,35(4):285–291.PubMed CentralPubMed
  2. European Committee for Standardization (CEN): Workplace atmospheres-size fraction definitions for measurement of airborne particles (Report No. BS EN 481:1993). London, England: CEN, British Standards Institute; 1993.
  3. American Conference of Governmental Industrial Hygienis (ACGIH): TLVs and BEIs: Based on the documentation of the threshold limit values for chemical substances and physical agents and biological exposure indices. Cincinnati, OH: ACGIH; 2005.
  4. American Conference of Governmental Industrial Hygienis (ACGIH): Particle size-selective sampling in the workplace. Report of the ACGIH Technical Committee on Air Sampling Procedures. Cincinnati, OH: ACGIH; 1985.
  5. Lippmann M: Regional deposition of particles in the human respiratory tract. In Handbook of Physiology – Reactions to Environmental Agents. Edited by: Lee DHK, Falk HL, Murphy SD, Geiger SR, Bethesda MD. : American Physiological Society; 1977:213–232.
  6. Stahlhofen W, Gebhart J, Heyder J: Experimental determination of the regional deposition of aerosol particles in the human respiratory tract. Am Ind Hyg Assoc J 1980, 41: 385–398. 10.1080/15298668091424933View ArticlePubMed
  7. Chan TL, Lippmann M: Experimental measurements and empirical modelling of the regional deposition of inhaled particles in humans. Am Ind Hyg Assoc J 1980, 41: 399–409. 10.1080/15298668091424942View ArticlePubMed
  8. U.S. Environmental Protection Agency (U.S. EPA): Revisions to the national ambient air quality standards for particulate matter. Fed Regist 1987,52(July 1):24634–24669.
  9. U.S. Environmental Protection Agency (U.S. EPA): National ambient air quality standards for particulate matter; final rule. Fed Regist 1997,62(July 18):38652–38752.
  10. Miller FJ, Gardner JA, Graham JA, Lee RE, Willson WE, Bachmann JD: Size considerations for establishing a standard for inhalable particles. J Air Pollut Control Assoc 1979, 29: 610–615. 10.1080/00022470.1979.10470831View Article
  11. International Organization for Standardization (ISO): Air quality – Sampling conventions for airborne particle deposition in the human respiratory system. Geneva, Switzerland: ISO 13138, First edition; 2012.
  12. International Commission on Radiological Protection (ICRP): Human respiratory tract model for radiological protection: a report of a task group of the International Commission on Radiological Protection. Ann ICRP 1994,24(1–3):1–482.View Article
  13. Bennett WD, Scheuch G, Zeman KL, Brown JS, Kim C, Heyder J, Stahlhofen W: Bronchial airway deposition and retention of particles in inhaled boluses: effect of anatomic dead space. J Appl Physiol 1998, 85: 685–694.PubMed
  14. Smith JR, Bailey MR, Etherington G, Shutt AL, Youngman MJ: Effect of particle size on slow particle clearance from the bronchial tree. Exp Lung Res 2008, 34: 287–312. 10.1080/01902140802093196View ArticlePubMed
  15. Svartengren M, Falk R, Philipson K: Long-term clearance from small airways decreases with age. Eur Respir J 2005, 26: 609–615. 10.1183/09031936.05.00002105View ArticlePubMed
  16. Brochu P, Ducré-Robitaille JF, Brodeur J: Physiological Daily Inhalation Rates for Free-Living Individuals Aged 1 Month to 96 Years, Using Data from Doubly Labeled Water Measurements: A Proposal for Air Quality Criteria, Standard Calculations and Health Risk Assessment. Hum Ecol Risk Assess 2006,12(4):675–701. 10.1080/10807030600801550View Article
  17. Niinimaa V, Cole P, Mintz S, Shephard RJ: Oronasal distribution of respiratory airflow. Respir Physiol 1981,43(1):69–75. 10.1016/0034-5687(81)90089-XView ArticlePubMed
  18. Becquemin MM, Bertholon JF, Bouchikhi A, Malarbet JL, Roy M: Oronasal Ventilation Partitioning in Adults and Children: Effect on Aerosol Deposition in Airways. Radiat Prot Dosimetry 1999, 81: 221–228. 10.1093/oxfordjournals.rpd.a032588View Article
  19. Bennett WD, Zeman KL, Jarabek AM: Nasal contribution to breathing and fine particle deposition in children versus adults. J Toxicol Environ Health A Curr Iss 2008, 71: 227–237.View Article
  20. Bennett W, Zeman K, Jarabek A: Nasal contribution to breathing with exercise: effect of race and gender. J Appl Physiol 2003, 95: 497–503.View ArticlePubMed
  21. James DS, Lambert WE, Mermier CM, Stidley CA, Chick TW, Samet JM: Oronasal distribution of ventilation at different ages. Arch Environ Health 1997,52(2):118–123. 10.1080/00039899709602874View ArticlePubMed
  22. Becquemin MH, Swift DL, Bouchikhi A, Roy M, Teillac A: Particle deposition and resistance in the noses of adults and children. Eur Respir J 1991, 4: 694–702.PubMed
  23. Anjilvel S, Asgharian B: A multiple-path model of particle deposition in the rat lung. Fundam Appl Toxicol 1995, 28: 41–50. 10.1006/faat.1995.1144View ArticlePubMed
  24. Yeh HC, Schum GM: Models of human lung airways and their application to inhaled particle deposition. Bull Math Biol 1980, 42: 461–480.View ArticlePubMed
  25. De Winter-Sorkina R, Cassee FR: From concentration to dose: Factors influencing airborne particulate matter deposition in humans and rats. Bilthoven, The Netherlands: National Institute of Public Health and the Environment RIVM, report 650010031/2002; 2002. Available: (accessed 7 Jan 2011) http://​www.​rivm.​nl/​bibliotheek/​rapporten/​650010031.​html
  26. International Organization for Standardization (ISO): Size definitions for particle sampling: recommendations of ad hoc working group appointed by Committee TC 146 of the International Standards Organization. Am Ind Hyg Assoc J 1981,42(5):A64-A68.
  27. International Organization for Standardization (ISO): Air quality – Particle size fraction definitions for health related sampling. Geneva, Switzerland: Technical Report ISO/TR; 1983:7708–1983.
  28. U.S. Environmental Protection Agency (U.S. EPA): Integrated Science Assessment for Particulate Matter. Research Triangle Park, NC: National Center for Environmental Assessment, Office of Research and Development, U.S. EPA; 2009. EPA/600/R-08/139F
  29. Chadha TS, Birch S, Sacker MA: Oronasal distribution of ventilation during exercise in normal subjects and patients with asthma and rhinitis. Chest 1987,92(6):1037–1041. 10.1378/chest.92.6.1037View ArticlePubMed
  30. Bennett WD, Zeman KL, Kang CW, Schechter MS: Extrathoracic deposition of inhaled, coarse particles (4.5 μm) in children vs. adults. Ann Occup Hyg. In Inhaled particles VIII: proceedings of an international symposium on inhaled particles organized by the British Occupational Hygiene Society; August 1996. Edited by: Cherry N, Ogden T. Cambridge, UK; 1997:497–502. 41(suppl. 1)
  31. Brown JS: Particle inhalability at low wind speeds. Inhal Toxicol 2005,17(14):831–837. 10.1080/08958370500241296View ArticlePubMed
  32. Millage KK, Bergman J, Asgharian B, McClellan G: A review of inhalability fraction models: discussion and recommendations. Inhal Toxicol 2010,22(2):151–159. 10.3109/08958370903025973View ArticlePubMed
  33. Lippmann M: Size-selective health hazard sampling. In Air Sampling Instruments for evaluation of atmospheric contaminants, 9th ed. Edited by: Choen BS, McCammon CSJr. Cincinnati, OH: ACGIH Worldwide; 2001. 1–882417–39–9

Copyright

© Brown et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement